CLINICAL_TRIALS
research
· 2019-07-01
Clinical Trial Update: Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes [Phase 4]
Summary
Phase 4 clinical trial assessing how dietary factors influence the glucose-lowering effects of sitagliptin in adults with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kansai Electric Power Hospital | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2019-07-01